Author

Antonio Rosato

University of PaduaORCID 0000-0002-5263-8386Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Antonio Rosato2 papers · Istituto Oncologico Veneto

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Alessandro PalmioliiD· 1 shared Anna PolicastroiD· 1 shared Anna TosiiD· 1 shared Annica BarizzaiD· 1 shared Aurora MaurizioiD· 1 shared Benedetta Mattorre· 1 shared Chiara Della BellaiD· 1 shared Cristina AiroldiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alessandro PalmioliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming

Annica Barizza, Stefania Vassallo, Laura Masatti, Mattia Laffranchi, Sofia Giacometti, Silvia Lonardi, Mattia Bugatti, Sara Coletta, Chiara Della Bella, Mario Milco D’Elios, Simone Pizzini, Antonio Rosato, William Vermi, Matteo Fassan, Gaya Spolverato, , Gaia Codolo

This study identifies CD300e as a driver of immunosuppressive tumor microenvironment in colorectal cancer by reprogramming macrophages to suppress T-cell function and promote tumor growth.

Journal for ImmunoTherapy of Cancer · Dec 1, 2025Peer-reviewedCancer Biology

Microbiome Modulation Uncouples Efficacy and Toxicity Induced by Programmed Death-1/Programmed Death-Ligand1 Blockade

Laura Lucia Cogrossi, Anna Policastro, Paola Zordan, Matteo Grioni, Anna Tosi, Nathalie RIZZO, Benedetta Mattorre, Marco Lorenzoni, Greta Meregalli, Sofia Sisti, Francesca Sanvito, Alessandro Palmioli, Cristina Airoldi, Aurora Maurizio, Marta Chesi, , Matteo Bellone

This study shows that administering Prevotella melaninogenica to mice with multiple myeloma delays disease progression and enhances the efficacy of PD-1/PD-L1 blockade while reducing toxicity.

Nature Communications · Nov 24, 2025Peer-reviewedImmunology